ctrl K

Werewolf Therapeutics Inc... (HOWL)

NASDAQ: HOWL · Real-Time Price · USD

0.87

-0.03 (-3.58%)

At close: May 01, 2025, 3:59 PM

0.91

4.19%

After-hours: May 01, 2025, 06:53 PM EDT

Werewolf Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1.89M	19.94M	16.4M	n/a	n/a	n/a
Cost of Revenue	1.81M	38.91M	2.51M	735K	777K	463K
Gross Profit	71K	-18.96M	13.89M	-735K	-777K	-463K
Operating Income	-73.59M	-40.5M	-56.06M	-50.09M	-22.4M	-9.94M
Interest Income	6.67M	7.42M	1.91M	104K	101K	372K
Pretax Income	-70.52M	-37.37M	-53.81M	-49.98M	-15.04M	-10.25M
Net Income	-70.52M	-37.37M	-51.56M	-49.77M	-14.94M	-10.99M
Selling & General & Admin	19.05M	18.67M	18.7M	14.82M	5.76M	3.6M
Research & Development	56.43M	41.78M	53.76M	35.27M	16.64M	6.34M
Other Expenses	n/a	n/a	2.25M	104K	7.26M	430K
Operating Expenses	75.48M	60.45M	72.46M	50.09M	22.4M	9.94M
Interest Expense	4.66M	3.14M	n/a	n/a	n/a	372K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	75.48M	60.45M	72.46M	50.09M	22.4M	9.94M
Income Tax Expense	n/a	n/a	-2.25M	-216K	-101K	742K
Shares Outstanding (Basic)	43.33M	35.65M	28.86M	27.31M	28.66M	28.66M
Shares Outstanding (Diluted)	43.86M	35.65M	28.86M	27.31M	28.66M	28.66M
EPS (Basic)	-1.63	-1.05	-1.79	-1.82	-0.52	-0.38
EPS (Diluted)	-1.61	-1.05	-1.79	-1.82	-0.52	-0.38
EBITDA	-64.05M	-32.47M	-51.3M	-49.25M	-14.26M	-9.41M
EBIT	-65.86M	-34.23M	-53.81M	-49.98M	-15.04M	-9.88M
Depreciation & Amortization	1.81M	1.76M	2.51M	735K	777K	463K